Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Vaccine Effectiveness × Gynecologic × 1 year × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 799 Uterine Cervical Neoplasms 540 Endometrial Neoplasms 461 Breast Neoplasms 220 Fallopian Tube Neoplasms 208 Colorectal Neoplasms 170 Carcinoma, Non-Small-Cell Lung 158 Neoplasms 146 Stomach Neoplasms 130 Pancreatic Neoplasms 123 Prostatic Neoplasms 107 Melanoma 105 Lung Neoplasms 104 Neoplasm Metastasis 102 Triple Negative Breast Neoplasms 95 Carcinoma, Ovarian Epithelial 85 Squamous Cell Carcinoma of Head and Neck 82 Urinary Bladder Neoplasms 78 Esophageal Neoplasms 77 Carcinoma, Renal Cell 77 Head and Neck Neoplasms 75 Uterine Neoplasms 68 Vulvar Neoplasms 65 Colonic Neoplasms 60 Peritoneal Neoplasms 58 Uterine Cervical Dysplasia 57 Carcinoma, Hepatocellular 56 Sarcoma 51 Carcinoma, Transitional Cell 47 Papillomavirus Infections 46

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07256912 2026-03-24

CervALONE

International Agency for Research on Cancer

Phase 4 Not yet recruiting

Vaccine Effectiveness

Data powered by HemOnc (CC BY 4.0) Colophon ⚡